Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
99% of clinical trials for Alzheimer’s disease fail to show positive results, but researchers remain optimistic that new disease-modifying treatments are on the horizon
Dogs develop diseases similar to those of humans, and their inbred genetics makes them a useful model for disease biology, allowing the development of new therapies for veterinary and human use.
Leading researchers explain how the COVID-19 pandemic has spurred research on wearables, genomic surveillance, behavioral interventions and drug discovery.
Designing a new drug is not enough; it has to be delivered to its target, which can be achieved via a cornucopia of vehicles, from nanoparticles and microneedles to red blood cells and microalgae.
Cancer immunotherapy is generating huge excitement, but the future may lie elsewhere, in antibody–drug conjugates, proteolysis-targeting chimeras, and liquid biopsy for early detection.
Theranostics aim to both diagnose and treat cancer. Although few such drugs are on the market, many are being tested in clinical trials, with early results showing promise.
Drones are increasingly used to deliver essential health supplies in remote, underserved and Indigenous communities, but drone suppliers are keen to expand into the lucrative prescription drug market in the US.
The pandemic is far from over in Africa, but there is also a funding gap in preparing for endemic COVID-19, which will require long-term investment in healthcare infrastructure.
Flying to space takes its toll on the human body, and this has spurred new research on radiation and microgravity, as well as advances in remote medicine and telehealth, all of which have potential benefits for people on Earth.
Medical discoveries have been shared at an unprecedented pace during the COVID-19 pandemic, but so have fraudulent studies, which has led to worries about scientific integrity.
During the COVID-19 pandemic, the public have turned to scientists and doctors for vital information. But science communication is a skill in itself, so we asked the experts to share their tips.
Tracking the coronavirus SARS-CoV-2, developing treatments and testing vaccines have relied on access to the health data of millions of people. This massive trove could be used to understand other diseases, but not everyone is convinced.
Misinformation about COVID-19 vaccines often starts life in Europe or the United States but has found fertile ground in Africa, which poses a challenge for local health leaders.
mRNA vaccines are now in the limelight as a key tool for tackling COVID-19, but the technology was originally developed for other diseases, such as cancer, that researchers are now hoping to treat.